Herbalife (HLF) Buyback Puts Its Undervalued Narrative To The Test
Herbalife buyback puts capital return in focus
Herbalife (HLF) has put fresh attention on its capital return plans after the Board authorized a share repurchase program of up to $250 million, scheduled to run over three years.
Herbalife’s buyback arrives after a mixed stretch for the stock, with the 1-year total shareholder return of 30.23% contrasting with a share price that is down 7.25% year to date and 6.01% over the past month, hinting at fading short term momentum as management directs fresh capital into repurchases.
Compare Herbalife's fresh buyback with other companies returning cash to shareholders by scanning our 35 high quality undervalued stocks, which already combine solid fundamentals with what could be discounted prices.
Herbalife now has a fresh buyback plan, a mixed share price record and a market value of about US$1.25b. Does that create an attractive balance between risk and reward, or has the easy upside already been taken?
Most Popular Narrative: 30% Undervalued
Herbalife is priced at $11.89, while the most followed narrative pegs fair value at $17.00. This points to a sizeable valuation gap that this new buyback now sits on top of.
The company continues to experience flat to declining volumes in several regions, with only modest improvements in constant currency net sales. This indicates that the addressable market for Herbalife's traditional model may be reaching maturity and that top-line revenue growth could remain pressured.
Ongoing reliance on network recruiting and regional distributor growth increases vulnerability to macroeconomic downturns and currency headwinds in emerging markets. This may result in heightened volatility in both revenue and net margins.
See why 9 investors see Herbalife as 30% undervalued.
Result: Fair Value of $17.00 (UNDERVALUED)
Still, Herbalife’s push into personalized wellness technology and its focus on debt reduction could reshape cash flow and continue to challenge the current undervalued narrative.
Find out about the key risks to this Herbalife narrative.
Next Steps
Mixed views on Herbalife's valuation and capital return are clear, so weigh those signals for yourself and move fast to judge the balance of risk and upside. To see how the trade off looks when you put the data side by side, review the 3 key rewards and 4 important warning signs
Looking for more Herbalife style investment ideas?
If Herbalife has you thinking harder about price, quality and risk, do not stop with a single ticker. Use the Simply Wall Street Screener to line up fresh ideas before the crowd notices.
- Target value first by scanning companies on our 35 high quality undervalued stocks that pair strong fundamentals with what may be compressed valuations.
- Prioritize resilience by checking the 30 resilient stocks with low risk scores so you can focus on businesses with sturdier risk profiles.
- Hunt for future leaders by reviewing the 16 high quality undiscovered gems before they move onto everyone else's radar.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com